TScan Therapeutics, Inc. ($TCRX)
Filing Information
| Accession Number | 0000902664-25-005396 |
|---|---|
| Form Type | 4 |
| Filing Date | Dec 23, 2025 |
| Document Date | Dec 19, 2025 |
| Document | View SEC Filing |
Transactions
3
Total Shares
161,801
Total Value
$145,525.97
P&L
+17.9% (+$25,983.09)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common stock, $0.0001 par value per share ("Common Stock") | โ | Dec 19, 2025 | Purchase | 80,069 | $0.90 | $71,974.02 | 7,937,416 | Indirect | See footnote | View Details | |
10% Owner | Common Stock | โ | Dec 22, 2025 | Purchase | 75,500 | $0.90 | $67,950.00 | 8,012,916 | Indirect | See footnote | View Details | |
10% Owner | Common Stock | โ | Dec 23, 2025 | Purchase | 6,232 | $0.90 | $5,601.94 | 8,019,148 | Indirect | See footnote | View Details |